NCT03480152 2020-06-02Messenger RNA (mRNA)-Based, Personalized Cancer Vaccine Against Neoantigens Expressed by the Autologous CancerNational Institutes of Health Clinical Center (CC)Phase 1/2 Terminated5 enrolled 11 charts